The impact of antibiotic prescription rates on the incidence of MRSA bloodstream infections: A county-level, US-wide analysis.

Objectives To investigate the association of methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infection with socioeconomic factors and antibiotic prescriptions at the county level. Methods MRSA bloodstream infection rates were extracted from the Medicare Hospital Compare database. Data on socioeconomic factors and antibiotic prescriptions were obtained from the US Census Bureau and the Medicare Part D database, respectively. Results In multivariate analysis, antibiotic prescriptions demonstrated a powerful positive association with MRSA bloodstream infection rates [Coefficient (Coeff): 0.432, 95% Confidence Interval (CI): 0.389, 0.474, P < 0.001], which was largely attributable to lincosamides (Coeff: 0.257, 95% CI: 0.177, 0.336, P < 0.001), glycopeptides (Coeff: 0.223, 95% CI: 0.175, 0.272, P < 0.001), and sulfonamides (Coeff: 0.166, 95% CI: 0.082, 0.249, P < 0.001). Sociodemographic factors, such as poverty (Coeff: 0.094, 95% CI: 0.034, 0.155, P =0.002) exerted a secondary positive impact on MRSA bloodstream infection. Conversely, college education (Coeff: −0.037, 95% CI: −0.068, −0.005, P =0.024), a larger median room number per house (Coeff: −0.107, 95% CI: −0.134, −0.081, P < 0.001), and an income above the poverty line (100% < income < 150% of the poverty line) (Coeff: −0.257, 95% CI: −0.314, −0.199, P < 0.001) were negatively associated with MRSA incidence rates. A multivariate model that incorporated socioeconomic data and antibiotic prescription rates predicted 39.1% of the observed variation in MRSA bloodstream infection rates (Pmodel < 0.001). Conclusions MRSA bloodstream infection rates were strongly associated with county-level antibiotic use and socioeconomic factors. If the causality of these associations is confirmed, antimicrobial stewardship programs that extend outside acute healthcare facilities would likely prove instrumental in arresting the spread of MRSA. [ABSTRACT FROM AUTHOR]